Hans Sägesser

880 total citations
21 papers, 706 citations indexed

About

Hans Sägesser is a scholar working on Hepatology, Epidemiology and Physiology. According to data from OpenAlex, Hans Sägesser has authored 21 papers receiving a total of 706 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Hepatology, 9 papers in Epidemiology and 7 papers in Physiology. Recurrent topics in Hans Sägesser's work include Liver Disease and Transplantation (13 papers), Liver Disease Diagnosis and Treatment (9 papers) and Nitric Oxide and Endothelin Effects (6 papers). Hans Sägesser is often cited by papers focused on Liver Disease and Transplantation (13 papers), Liver Disease Diagnosis and Treatment (9 papers) and Nitric Oxide and Endothelin Effects (6 papers). Hans Sägesser collaborates with scholars based in Switzerland, Germany and United States. Hans Sägesser's co-authors include Jürg Reichen, Jürg Reichen, Andrea De Gottardi, M Ledermann, Vreni Schneider, Heinz Zimmermann, Sidney Shaw, Arthur Zimmermann, Erwin Biecker and Detlef Schuppan and has published in prestigious journals such as Gastroenterology, Hepatology and Journal of Hepatology.

In The Last Decade

Hans Sägesser

21 papers receiving 692 citations

Peers

Hans Sägesser

HEPAT

EPIDE

SURGE

PRM

Koichi Shiraishi Japan

Atsuhiro Morita Japan

Dominique Crénesse France

André Gauthier France

Aimee L. Anderson United States

Eduardo Martínez‐Ansó Spain

H Moriwaki Japan

John Poulos United States

E Song South Africa

Hyo‐Suk Lee South Korea

Koichi Shiraishi Japan

Hans Sägesser

321 ×0.9

HEPAT

363 ×1.4

EPIDE

153 ×0.7

SURGE

200 ×1.6

52 ×0.4

PRM

Citations per year, relative to Hans Sägesser Hans Sägesser (= 1×) peers Koichi Shiraishi

Countries citing papers authored by Hans Sägesser

Since Specialization

Citations

This map shows the geographic impact of Hans Sägesser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hans Sägesser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hans Sägesser more than expected).

Fields of papers citing papers by Hans Sägesser

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hans Sägesser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hans Sägesser. The network helps show where Hans Sägesser may publish in the future.

Co-authorship network of co-authors of Hans Sägesser

This figure shows the co-authorship network connecting the top 25 collaborators of Hans Sägesser. A scholar is included among the top collaborators of Hans Sägesser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hans Sägesser. Hans Sägesser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Moghadamrad, Sheida, Kathy D. McCoy, Markus B. Geuking, et al.. (2015). Attenuated portal hypertension in germ‐free mice: Function of bacterial flora on the development of mesenteric lymphatic and blood vessels. Hepatology. 61(5). 1685–1695. 50 indexed citations

Patsenker, Eleonora, Yury Popov, Felix Stickel, et al.. (2009). Pharmacological inhibition of integrin αvβ3 aggravates experimental liver fibrosis and suppresses hepatic angiogenesis #. Hepatology. 50(5). 1501–1511. 131 indexed citations

Knapp, Andrea, Konstantin Beier, Luigi Terracciano, et al.. (2007). Toxicity of Valproic Acid in Mice with Decreased Plasma and Tissue Carnitine Stores. Journal of Pharmacology and Experimental Therapeutics. 324(2). 568–575. 37 indexed citations

Gottardi, Andrea De, Erwin Biecker, Abraham Koshy, et al.. (2006). Sensitivity to endothelin-1 is decreased in isolated livers of endothelial constitutive nitric oxide synthase knockout mice. PubMed. 5(1). 9–9. 1 indexed citations

Biecker, Erwin, Andrea De Gottardi, Markus Neef, et al.. (2005). Long-Term Treatment of Bile Duct-Ligated Rats with Rapamycin (Sirolimus) Significantly Attenuates Liver Fibrosis: Analysis of the Underlying Mechanisms. Journal of Pharmacology and Experimental Therapeutics. 313(3). 952–961. 69 indexed citations

Biecker, Erwin, Hans Sägesser, & Jürg Reichen. (2004). Vasodilator mRNA levels are increased in the livers of portal hypertensive NO‐synthase 3‐deficient mice. European Journal of Clinical Investigation. 34(4). 283–289. 19 indexed citations

Biecker, Erwin, Markus Neef, Hans Sägesser, et al.. (2004). Nitric oxide synthase 1 is partly compensating for nitric oxide synthase 3 deficiency in nitric oxide synthase 3 knock‐out mice and is elevated in murine and human cirrhosis. Liver International. 24(4). 345–353. 22 indexed citations

Schäfer, Markus, Hans Sägesser, J. Reichen, & L. Krähenbühl. (2001). Alterations in hemodynamics and hepatic and splanchnic circulation during laparoscopy in rats. Surgical Endoscopy. 15(10). 1197–1201. 51 indexed citations

Casteele, Marc Van de, Hans Sägesser, Heinz Zimmermann, & Jürg Reichen. (2001). Characterisation of portal hypertension models by microspheres in anaesthetised rats: a comparison of liver flow. Pharmacology & Therapeutics. 90(1). 35–43. 27 indexed citations

10.

Gottardi, Andrea De, Андреас Каппелер, Sidney Shaw, et al.. (2001). Overexpression of endothelin-1 in bile duct ligated rats: correlation with activation of hepatic stellate cells and portal pressure. Journal of Hepatology. 34(1). 38–45. 37 indexed citations

11.

Gottardi, Andrea De, Sidney Shaw, Hans Sägesser, & Jürg Reichen. (2000). Type A, but not type B, endothelin receptor antagonists significantly decrease portal pressure in portal hypertensive rats. Journal of Hepatology. 33(5). 733–737. 16 indexed citations

12.

Casteele, Marc Van de, et al.. (1999). Intraportal administration of glyceryl trinitrate or nitroprusside exerts more systemic than intrahepatic effects in anaesthetised cirrhotic rats. Journal of Hepatology. 31(2). 300–305. 14 indexed citations

13.

Reichen, Jürg, et al.. (1998). The effect of endothelin and its antagonist Bosentan on hemodynamics and microvascular exchange in cirrhotic rat liver. Journal of Hepatology. 28(6). 1020–1030. 67 indexed citations

14.

Flück, Martin, et al.. (1998). Sinusoidal but not prehepatic portal pressure is associated with decreased hepatic no synthase (NOS) activity. Journal of Hepatology. 28. 76–76. 1 indexed citations

15.

Lebbé, Célèste, et al.. (1997). Targeting Naproxen to Non-Parenchymal Liver Cells Protects Against Endotoxin Induced Liver Damage. Journal of drug targeting. 4(5). 303–310. 9 indexed citations

16.

Albrecht, Christiane, Dirk K. F. Meijer, Célèste Lebbé, et al.. (1997). Targeting naproxen coupled to human serum albumin to nonparenchymal cells reduces endotoxin-induced mortality in rats with biliary cirrhosis. Hepatology. 26(6). 1553–1559. 13 indexed citations

17.

Elsing, Christoph, Hans Sägesser, & Jürg Reichen. (1994). Ursodeoxycholate–Induced Hypercholeresis in Cirrhotic Rats: Further Evidence for Cholehepatic Shunting. Hepatology. 20(4). 1048–1054. 11 indexed citations

18.

Zimmermann, Heinz, et al.. (1993). Biliary retention in a chronic choledocho-venous fistula in the rat: Induction of portal hypertension but not of biliary cirrhosis. Journal of Hepatology. 19(1). 110–116. 1 indexed citations

19.

Zimmermann, Heinz, et al.. (1992). Reversibility of secondary biliary fibrosis by biliodigestive anastomosis in the rat. Gastroenterology. 103(2). 579–589. 85 indexed citations

20.

Reichen, Jürg, Stephan Krähenbühl, A Küpfer, Hans Sägesser, & Georg Karlaganis. (1986). Defective bile acid transport in an animal model of defective debrisoquine hydroxylation. Biochemical Pharmacology. 35(5). 753–759. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact